Authors: Sancken, U Bartels, I

Citation: U. Sancken et I. Bartels, Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate ininsulin-dependent diabetes mellitus (IDDM)?, PRENAT DIAG, 21(5), 2001, pp. 383-386

Authors: Sancken, U Bartels, I

Citation: U. Sancken et I. Bartels, Preliminary data on an association between blood groups and serum markers used for the so-called 'triple screening': free oestriol MoM values are decreased in rhesus-negative (Rh-) women, PRENAT DIAG, 21(3), 2001, pp. 194-195

Authors: Sancken, U Bartels, I Louwen, F Eiben, B

Citation: U. Sancken et al., A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: Experience of two laboratories, PRENAT DIAG, 19(10), 1999, pp. 947-954

Authors: Moghadam, S Engel, W Bougoussa, M Hennen, G Igout, A Sancken, U

Citation: S. Moghadam et al., Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: Implications for prenatal diagnosis of trisomy 21, FETAL DIAGN, 13(5), 1998, pp. 291-297